Cargando…
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
OBJECTIVES: Antibody testing against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been instrumental in detecting previous exposures and analyzing vaccine‐elicited immune responses. Here, we describe a scalable solution to detect and quantify SARS‐CoV‐2 antibodies, discriminate be...
Autores principales: | Colwill, Karen, Galipeau, Yannick, Stuible, Matthew, Gervais, Christian, Arnold, Corey, Rathod, Bhavisha, Abe, Kento T, Wang, Jenny H, Pasculescu, Adrian, Maltseva, Mariam, Rocheleau, Lynda, Pelchat, Martin, Fazel‐Zarandi, Mahya, Iskilova, Mariam, Barrios‐Rodiles, Miriam, Bennett, Linda, Yau, Kevin, Cholette, François, Mesa, Christine, Li, Angel X, Paterson, Aimee, Hladunewich, Michelle A, Goodwin, Pamela J, Wrana, Jeffrey L, Drews, Steven J, Mubareka, Samira, McGeer, Allison J, Kim, John, Langlois, Marc‐André, Gingras, Anne‐Claude, Durocher, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942165/ https://www.ncbi.nlm.nih.gov/pubmed/35356067 http://dx.doi.org/10.1002/cti2.1380 |
Ejemplares similares
-
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard
por: Saeed, Sahar, et al.
Publicado: (2021) -
Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays
por: Tuite, Ashleigh R., et al.
Publicado: (2022) -
Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
por: Maltseva, Mariam, et al.
Publicado: (2022) -
Resistance of SARS‐CoV‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020
por: Drews, Steven J., et al.
Publicado: (2021) -
A simple protein-based surrogate neutralization assay for SARS-CoV-2
por: Abe, Kento T., et al.
Publicado: (2020)